{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:58:12Z","timestamp":1792511892473,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021A1515010478"],"award-info":[{"award-number":["2021A1515010478"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021177","name":"Shenzhen Bay Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021177","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013136","name":"Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering, and Tracking","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032554","name":"Peking University Shenzhen Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Insight"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cellin.2025.100251","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T11:49:26Z","timestamp":1747050566000},"page":"100251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Rapid and direct discovery of functional tumor specific neoantigens by high resolution mass spectrometry and novel algorithm prediction"],"prefix":"10.1016","volume":"4","author":[{"given":"Huajian","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6967-7675","authenticated-orcid":false,"given":"Cookson K.C.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suping","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangxue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellin.2025.100251_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1411352","article-title":"Advances and challenges in anti-cancer vaccines for multiple myeloma","volume":"15","author":"Abdollahi","year":"2024","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.cellin.2025.100251_bib2","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.e17589","article-title":"Sipuleucel-T (sip-T) and oral androgen axis inhibitors in black men being treated for metastatic castration-resistance prostate cancer (mCRPC): Observations from the Medicare Fee for Service (FFS) population","volume":"38","author":"Borno","year":"2020","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.cellin.2025.100251_bib3","article-title":"Peptide-based vaccine for cancer therapies","volume":"14","author":"Buonaguro","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.cellin.2025.100251_bib4","series-title":"Bispecific binding molecules","author":"Chervin","year":"2021"},{"key":"10.1016\/j.cellin.2025.100251_bib5","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1158\/1535-7163.MCT-22-0770","article-title":"ABBV-184: A novel survivin-specific TCR\/CD3 bispecific T-cell engager is active against both solid tumor and hematologic malignancies","volume":"22","author":"Chervin","year":"2023","journal-title":"Molecular Cancer Therapeutics"},{"issue":"11","key":"10.1016\/j.cellin.2025.100251_bib6","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1016\/j.ymthe.2024.08.018","article-title":"TALEN-edited allogeneic inducible dual CAR T cells enable effective targeting of solid tumors while mitigating off-tumor toxicity","volume":"32","author":"Dharani","year":"2024","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.cellin.2025.100251_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00448-5","article-title":"Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer","volume":"6","author":"Ding","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.cellin.2025.100251_bib8","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2018-5717","article-title":"Mass spectrometry as a tool for MHC class I and II neoantigen discovery","volume":"78","author":"Ford","year":"2018","journal-title":"Cancer Research"},{"key":"10.1016\/j.cellin.2025.100251_bib9","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2024-LB056","article-title":"IBI334, a novel ADCC-enhanced B7-H3\/EGFR bispecific antibody, demonstrated potent pre-clinical efficacy in solid tumors","volume":"84","author":"Guan","year":"2024","journal-title":"Cancer Research"},{"key":"10.1016\/j.cellin.2025.100251_bib10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-023-06834-7","article-title":"Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides","volume":"625","author":"Huang","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2025.100251_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fimmu.2020.00276","article-title":"T-cell immunotherapies targeting histocompatibility and tumor antigens in hematological malignancies","volume":"11","author":"Janelle","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.cellin.2025.100251_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cas.13131","article-title":"Prediction and prioritization of neoantigens: Integration of RNA sequencing data with whole-exome sequencing","volume":"108","author":"Karasaki","year":"2017","journal-title":"Cancer Science"},{"key":"10.1016\/j.cellin.2025.100251_bib13","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS3641","article-title":"A phase 2 multicenter, open-label, randomized, controlled trial in patients with stage II\/III colorectal cancer who are ctDNA positive following resection to compare efficacy of autogene cevumeran versus watchful waiting","volume":"40","author":"Kopetz","year":"2022","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.cellin.2025.100251_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41573-021-00387-y","article-title":"Identification of neoantigens for individualized therapeutic cancer vaccines","volume":"21","author":"Lang","year":"2022","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.cellin.2025.100251_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00262-010-0942-x","article-title":"Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used","volume":"60","author":"Lesterhuis","year":"2011","journal-title":"Cancer Immunology Immunotherapy"},{"key":"10.1016\/j.cellin.2025.100251_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146371","article-title":"Identification of novel HLA-A\u221724:02-Restricted epitope derived from a homeobox protein expressed in hematological malignancies","volume":"11","author":"Matsushita","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cellin.2025.100251_bib17","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: Indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.cellin.2025.100251_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2338984","article-title":"Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012-2023)","volume":"20","author":"Miao","year":"2024","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1016\/j.cellin.2025.100251_bib19","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.11606","article-title":"Identifying patient-specific neoepitopes for cell-based and vaccine immunotherapy targets in breast cancer patients by HLA typing and predicting MHC presentation from whole genome and RNA sequencing data","volume":"34","author":"Nguyen","year":"2016","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.cellin.2025.100251_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100080","article-title":"Sensitive immunopeptidomics by leveraging available large-scale multi-HLA spectral libraries, data-independent acquisition, and MS\/MS prediction","volume":"20","author":"Pak","year":"2021","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.cellin.2025.100251_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-1055-6","article-title":"Neoantigen vaccine: An emerging tumor immunotherapy","volume":"18","author":"Peng","year":"2019","journal-title":"Molecular Cancer"},{"key":"10.1016\/j.cellin.2025.100251_bib22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/14737140.2024.2373888","article-title":"First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor\/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLC","volume":"24","author":"Peterlin","year":"2024","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.cellin.2025.100251_bib23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2025.100251_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nm0398-321","article-title":"Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma","volume":"4","author":"Rosenberg","year":"1998","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cellin.2025.100251_bib25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2025.100251_bib26","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7755.DISP19-D084","article-title":"Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC)-final PROCEED analysis","volume":"29","author":"Sartor","year":"2020","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"key":"10.1016\/j.cellin.2025.100251_bib27","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/bioinformatics\/btac116","article-title":"TSAFinder: Exhaustive tumor-specific antigen detection with RNAseq","volume":"38","author":"Sharpnack","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cellin.2025.100251_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac010","article-title":"AggMapNet: Enhanced and explainable low-sample omics deep learning with feature-aggregated multi-channel networks","volume":"50","author":"Shen","year":"2022","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.cellin.2025.100251_bib29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s42256-021-00301-6","article-title":"Out-of-the-box deep learning prediction of pharmaceutical properties by broadly learned knowledge-based molecular representations","volume":"3","author":"Shen","year":"2021","journal-title":"Nature Machine Intelligence"},{"key":"10.1016\/j.cellin.2025.100251_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-2748-7_6","article-title":"T cell receptor engineering and analysis using the yeast display platform","author":"Smith","year":"2015","journal-title":"Yeast Surface Display"},{"key":"10.1016\/j.cellin.2025.100251_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/acs.jproteome.0c00386","article-title":"Mild acid elution and MHC immunoaffinity chromatography reveal similar albeit not identical profiles of the HLA class I immunopeptidome","volume":"20","author":"Sturm","year":"2021","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/j.cellin.2025.100251_bib32","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","article-title":"T-cell transfer therapy targeting mutant KRAS in cancer","volume":"375","author":"Tran","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.cellin.2025.100251_bib33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.1251102","article-title":"Cancer immunotherapy based on mutation-specific CD4+T cells in a patient with epithelial cancer","volume":"344","author":"Tran","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.cellin.2025.100251_bib34","article-title":"Approved CAR-T therapies have reproducible efficacy and safety in clinical practice","volume":"20","author":"Vera","year":"2024","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1016\/j.cellin.2025.100251_bib35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): A randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cellin.2025.100251_bib36","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1158\/2326-6066.CIR-23-0083","article-title":"Long-read sequencing reveals alternative splicing-driven, shared immunogenic neoepitopes regardless of SF3B1 status in uveal melanoma","volume":"11","author":"Yao","year":"2023","journal-title":"Cancer Immunology Research"}],"container-title":["Cell Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772892725000252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772892725000252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:27:18Z","timestamp":1762648038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772892725000252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2772892725000252"],"URL":"https:\/\/doi.org\/10.1016\/j.cellin.2025.100251","relation":{},"ISSN":["2772-8927"],"issn-type":[{"value":"2772-8927","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid and direct discovery of functional tumor specific neoantigens by high resolution mass spectrometry and novel algorithm prediction","name":"articletitle","label":"Article Title"},{"value":"Cell Insight","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellin.2025.100251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Wuhan University.","name":"copyright","label":"Copyright"}],"article-number":"100251"}}